Skip to main content

Articles

Page 1 of 64

  1. Triglyceride-glucose (TyG) index, a dependable indicator of insulin resistance, has been identified as a valid marker regarding multiple cardiovascular diseases. Nevertheless, the correlation of TyG index with...

    Authors: Huiruo Liu, Liangshan Wang, Xing Zhou, Hong Wang, Xing Hao, Zhongtao Du, Chenglong Li and Xiaotong Hou
    Citation: Cardiovascular Diabetology 2024 23:337
  2. Although insulin resistance (IR) is among the most frequent and pathogenically relevant complications accompanying childhood obesity, its role in modulating and exacerbating obesity pathophysiology has not yet...

    Authors: Álvaro González-Domínguez, Otto Savolainen, Jesús Domínguez-Riscart, Rikard Landberg, Alfonso Lechuga-Sancho and Raúl González-Domínguez
    Citation: Cardiovascular Diabetology 2024 23:336
  3. Observational studies have revealed associations between maternal lipid metabolites and gestational diabetes mellitus (GDM). However, whether these associations are causal remain uncertain.

    Authors: Yao Dong, An-qun Hu, Bai-xue Han, Meng-ting Cao, Hai-yan Liu, Zong-guang Li, Qing Li and Ying-jie Zheng
    Citation: Cardiovascular Diabetology 2024 23:335
  4. Although the “obesity paradox” is comprehensively elucidated in heart failure (HF) with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), the role of body composition in left v...

    Authors: Kang Fu, Youran Dong, Zhiyuan Wang, Junlin Teng, Congyi Cheng, Cong Su, Xiaoping Ji and Huixia Lu
    Citation: Cardiovascular Diabetology 2024 23:334
  5. The aim was to investigate the total prevalence of known and undiagnosed diabetes mellitus (DM), and the association of DM with perioperative complications following elective, infrarenal, open surgical (OSR) o...

    Authors: J. Wesche, T. Bakken, M. Vetrhus, K. O. Hufthammer, L. Aa Nyroenning, H. Fagertun, I. Saethre, B. H. Wold, C. Lyng, E. M. Pettersen, I. S. Kjellsen, E. T. Gubberud, S. Kiil, H. Loose, M. T. Helgeland, M. E. Altreuther…
    Citation: Cardiovascular Diabetology 2024 23:333
  6. In populations with chronic disease, skin autofluorescence (SAF), a measure of long-term fluorescent advanced glycation end-products (AGEs) accumulation in body tissues, has been associated with vascular endot...

    Authors: Juanita J. Fewkes, Aimee L. Dordevic, Margaret Murray, Gary Williamson and Nicole J. Kellow
    Citation: Cardiovascular Diabetology 2024 23:332
  7. Visceral adipose tissue in individuals with obesity is an independent cardiovascular risk indicator. However, it remains unclear whether adipose tissue influences common cardiovascular diseases, such as athero...

    Authors: Bei Guo, Tong-Tian Zhuang, Chang-Chun Li, Fuxingzi Li, Su-Kang Shan, Ming-Hui Zheng, Qiu-Shuang Xu, Yi Wang, Li-Min Lei, Ke-Xin Tang, Wenlu Ouyang, Jia-Yue Duan, Yun-Yun Wu, Ye-Chi Cao, Muhammad Hasnain Ehsan Ullah, Zhi-Ang Zhou…
    Citation: Cardiovascular Diabetology 2024 23:331
  8. Despite the detrimental impact of abnormal glucose metabolism on cardiovascular prognosis after myocardial infarction (MI), diabetes is both underdiagnosed and undertreated. We investigated associations betwee...

    Authors: Bashaaer Sharad, Nils Eckerdal, Martin Magnusson, Halldora Ögmundsdottir Michelsen, Amra Jujic, Matthias Lidin, Linda Mellbin, Nael Shaat, Ronnie Pingel, John Wallert, Emil Hagström and Margrét Leósdóttir
    Citation: Cardiovascular Diabetology 2024 23:330
  9. The potential preventive effect of fenofibrate on lower extremity amputation (LEA) and peripheral arterial disease (PAD) in patients with type 2 diabetes (T2D) is not fully elucidated.

    Authors: Eu Jeong Ku, Bongseong Kim, Kyungdo Han, Seung-Hwan Lee and Hyuk-Sang Kwon
    Citation: Cardiovascular Diabetology 2024 23:329
  10. The aim of this study (EPIDIAB) was to assess the relationship between epicardial adipose tissue (EAT) and the micro and macrovascular complications (MVC) of type 2 diabetes (T2D).

    Authors: Bénédicte Gaborit, Jean Baptiste Julla, Joris Fournel, Patricia Ancel, Astrid Soghomonian, Camille Deprade, Adèle Lasbleiz, Marie Houssays, Badih Ghattas, Pierre Gascon, Maud Righini, Frédéric Matonti, Nicolas Venteclef, Louis Potier, Jean François Gautier, Noémie Resseguier…
    Citation: Cardiovascular Diabetology 2024 23:328
  11. Sodium-glucose cotransporter 2 inhibitors (SGLT-2is) have demonstrated associations with lowering cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). However, the impact of SGLT-2is on in...

    Authors: Chung-An Wang, Li-Chun Lin, Jui-Yi Chen, Wei-Jie Wang and Vin-Cent Wu
    Citation: Cardiovascular Diabetology 2024 23:327
  12. There is a growing burden of non-obese people with diabetes mellitus (DM). However, their cardiovascular risk (CV), especially in the presence of cardiovascular-kidney-metabolic (CKM) comorbidities is poorly c...

    Authors: Oliwia Janota, Marta Mantovani, Hanna Kwiendacz, Krzysztof Irlik, Tommaso Bucci, Steven H. M. Lam, Bi Huang, Uazman Alam, Giuseppe Boriani, Mirela Hendel, Julia Piaśnik, Anna Olejarz, Aleksandra Włosowicz, Patrycja Pabis, Wiktoria Wójcik, Janusz Gumprecht…
    Citation: Cardiovascular Diabetology 2024 23:326
  13. The relationship between ankle blood pressure (BP) and cardiovascular disease remains unclear. We examined the relationships between known and new ankle BP indices and major cardiovascular outcomes in people w...

    Authors: Kamel Mohammedi, Marie Pigeyre, Jackie Bosch, Salim Yusuf and Hertzel C. Gerstein
    Citation: Cardiovascular Diabetology 2024 23:325
  14. Heart failure with preserved ejection fraction (HFpEF) is common in type 2 diabetes mellitus (T2D), leading to high morbidity and mortality. Managing HFpEF in diabetic patients is challenging with limited trea...

    Authors: Arif Albulushi, Desmond Boakye Tanoh, Ahmed Almustafa, Nadya Al Matrooshi, Ronald Zolty and Brian Lowes
    Citation: Cardiovascular Diabetology 2024 23:324
  15. Diabetes mellitus (DM), prediabetes, and insulin resistance are highly prevalent in patients with ischemic stroke (IS). DM is associated with higher risk

    Authors: Nurcennet Kaynak, Valentin Kennel, Torsten Rackoll, Daniel Schulze, Matthias Endres and Alexander H. Nave
    Citation: Cardiovascular Diabetology 2024 23:323
  16. Continuous glucose monitoring (CGM) devices provide detailed information on daily glucose control and glycemic variability. Yet limited population-based studies have explored the association between CGM metric...

    Authors: Haili Zhong, Ke Zhang, Lishan Lin, Yan Yan, Luqi Shen, Hanzu Chen, Xinxiu Liang, Jingnan Chen, Zelei Miao, Ju-Sheng Zheng and Yu-ming Chen
    Citation: Cardiovascular Diabetology 2024 23:322
  17. The association between baseline triglyceride glucose index (TyG index) and incident non-communicable diseases, mainly in Asian populations, has been reported. In the current study, we aimed to evaluate the as...

    Authors: Danial Molavizadeh, Neda Cheraghloo, Maryam Tohidi, Fereidoun Azizi and Farzad Hadaegh
    Citation: Cardiovascular Diabetology 2024 23:321
  18. Numerous observational studies have demonstrated that circulating lipoprotein(a) [Lp(a)] might be inversely related to the risk of type 2 diabetes (T2D). However, recent Mendelian randomization (MR) studies do...

    Authors: Mateusz Lejawa, Marcin Goławski, Martyna Fronczek, Tadeusz Osadnik, Francesco Paneni, Massimiliano Ruscica, Natalia Pawlas, Małgorzata Lisik and Maciej Banach
    Citation: Cardiovascular Diabetology 2024 23:316
  19. Sodium-glucose cotransporter-2 (SGLT2) inhibitors have demonstrated reduction in heart failure outcomes in patients with type 2 diabetes mellitus, although the exact mechanism of benefit remains unclear. Alter...

    Authors: Marina Pourafkari, Kim A. Connelly, Subodh Verma, C. David Mazer, Hwee Teoh, Adrian Quan, Shaun G. Goodman, Archana Rai, Ming Yen Ng, Djeven P. Deva, Piero Triverio, Laura Jiminez-Juan, Andrew T. Yan and Yin Ge
    Citation: Cardiovascular Diabetology 2024 23:319
  20. Glucose metabolic disorder is associated with the risk of heart failure (HF). Adiposity is a comorbidity that is inextricably linked with abnormal glucose metabolism in older individuals. However, the effect o...

    Authors: Liming Hou, Xin Wang, Peilin Li, Hua Zhang, Yanli Yao, Zhendong Liu, Juan Wang and Weike Liu
    Citation: Cardiovascular Diabetology 2024 23:318
  21. Type 2 diabetes mellitus (T2DM) and metabolic-associated fatty liver disease (MAFLD) are both metabolic disorders that negatively impact the cardiovascular system. This study comprehensively analyzed the addit...

    Authors: Xin Tang, Rui Shi, Li Jiang, Wei-Feng Yan, Pei-Lun Han, Wen-Lei Qian, Zhi-Gang Yang and Yuan Li
    Citation: Cardiovascular Diabetology 2024 23:317
  22. Insulin resistance is a frequent precursor of typical obesity and metabolic syndrome complications. However, accurate diagnosis remains elusive because of its pathophysiological complexity and heterogeneity. H...

    Authors: Álvaro González-Domínguez, Jesús Domínguez-Riscart, Otto Savolainen, Alfonso Lechuga-Sancho, Rikard Landberg and Raúl González-Domínguez
    Citation: Cardiovascular Diabetology 2024 23:315
  23. Diabetic kidney disease (DKD) is associated with a higher risk of cardiovascular disease (CVD). Pentoxifylline (PTF), a nonselective phosphodiesterase inhibitor with anti-inflammatory, antiproliferative, and a...

    Authors: Javier Donate-Correa, Carla M. Ferri, Carmen Mora-Fernández, Nayra Pérez-Delgado, Ainhoa González-Luis and Juan F. Navarro-González
    Citation: Cardiovascular Diabetology 2024 23:314
  24. We used the Spanish national hospital discharge data from 2016 to 2022 to analyze procedures and hospital outcomes among patients aged ≥ 18 years admitted for ST-elevation myocardial infarction (STEMI) and non...

    Authors: Jose M. de-Miguel-Yanes, Rodrigo Jimenez-Garcia, Valentin Hernandez-Barrera, Javier de-Miguel-Diez, Ana Jimenez-Sierra, Jose J. Zamorano-León, Natividad Cuadrado-Corrales and Ana Lopez-de-Andres
    Citation: Cardiovascular Diabetology 2024 23:313
  25. The triglyceride glucose (TyG) index, as a reliable marker of insulin resistance, is associated with the incidence and poor prognosis of various cardiovascular diseases. However, the relationship between the T...

    Authors: Weiya Li, Hongde Li, Shiqin Peng, Junli Li, Yuan Feng, Yong Peng, Jiafu Wei, Zhengang Zhao, Tianyuan Xiong, Haoran Yang, Chengxiang Song, Lin Bai, Yijun Yao, Fei Chen, Yue Yin and Mao Chen
    Citation: Cardiovascular Diabetology 2024 23:312
  26. Typical bone proteins, such as sclerostin and periostin, have been associated with cardiovascular disease (CVD). Simultaneously, several risk scores have been developed to predict CVD in the general population...

    Authors: Sheila González-Salvatierra, Antonia García-Martín, Beatriz García-Fontana, Luis Martínez-Heredia, Cristina García-Fontana and Manuel Muñoz-Torres
    Citation: Cardiovascular Diabetology 2024 23:311
  27. The present umbrella review aims to collate and summarize the findings from previous meta-analyses on the Triglyceride and Glucose (TyG) Index, providing insights to clinicians, researchers, and policymakers reg...

    Authors: Sandeep Samethadka Nayak, Dona Kuriyakose, Lakshmi D. Polisetty, Anjali Avinash Patil, Daniyal Ameen, Rakshita Bonu, Samatha P. Shetty, Pubali Biswas, Micheal T. Ulrich, Negin Letafatkar, Arman Habibi, Mohammad-Hossein Keivanlou, Sara Nobakht, Abdulhadi Alotaibi, Soheil Hassanipour and Ehsan Amini-Salehi
    Citation: Cardiovascular Diabetology 2024 23:310
  28. The associations of risk factors with vascular impairment in type 1 diabetes patients seem more complex than that in type 2 diabetes patients. Therefore, we analyzed the associations between traditional and no...

    Authors: Pavlína Piťhová, Michaela Cichrová, Milan Kvapil, Jaroslav A. Hubáček, Dana Dlouhá and Jan Piťha
    Citation: Cardiovascular Diabetology 2024 23:309
  29. Albuminuria is considered an early and sensitive marker of kidney dysfunction, but also an independent cardiovascular risk factor. Considering the possible relationship among metabolic liver disease, cardiovas...

    Authors: Carolina M. Perdomo, Nerea Martin-Calvo, Ana Ezponda, Francisco J. Mendoza, Gorka Bastarrika, Nuria Garcia-Fernandez, José I. Herrero, Inmaculada Colina, Javier Escalada and Gema Frühbeck
    Citation: Cardiovascular Diabetology 2024 23:308
  30. The triglyceride-glucose (TyG) index and estimated glucose disposal rate (eGDR), which are calculated

    Authors: Hao-ming He, Ying-ying Xie, Qiang Chen, Yi-ke Li, Xue-xi Li, Ya-kun Mu, Xiao-yan Duo, Yan-xiang Gao and Jin-gang Zheng
    Citation: Cardiovascular Diabetology 2024 23:307
  31. Metabolic clusters can stratify subgroups of individuals at risk for type 2 diabetes mellitus and related complications. Since obesity and insulin resistance are closely linked to alterations in hemostasis, we...

    Authors: Sebastian Hörber, Katsiaryna Prystupa, Johann Jacoby, Andreas Fritsche, Marcus E. Kleber, Angela P. Moissl, Peter Hellstern, Andreas Peter, Winfried März, Robert Wagner and Martin Heni
    Citation: Cardiovascular Diabetology 2024 23:306
  32. The effect of plasma hepcidin concentrations on the long-term risk of developing adverse cardiovascular outcomes in people with type 2 diabetes mellitus (T2DM) is unclear.

    Authors: Alessandro Mantovani, Fabiana Busti, Nicolò Borella, Enrico Scoccia, Barbara Pecoraro, Elena Sani, Riccardo Morandin, Alessandro Csermely, Daniele Piasentin, Elisabetta Grespan, Annalisa Castagna, Josh Bilson, Christopher D. Byrne, Luca Valenti, Domenico Girelli and Giovanni Targher
    Citation: Cardiovascular Diabetology 2024 23:305
  33. Insulin resistance is linked to an increased risk of frailty, yet the comprehensive relationship between the triglyceride glucose-body mass index (TyG-BMI), which reflects weight, and frailty, remains unclear....

    Authors: Kai Guo, Qi Wang, Lin Zhang, Rui Qiao, Yujia Huo, Lipeng Jing, Xiaowan Wang, Zixuan Song, Siyu Li, Jinming Zhang, Yanfang Yang, Jinli Mahe and Zhengran Liu
    Citation: Cardiovascular Diabetology 2024 23:304
  34. Patients with diabetes have an increased risk of developing heart failure with preserved ejection fraction (HFpEF). This study aimed to compare indices of myocardial deformation and perfusion between patients ...

    Authors: Xin-Ni Li, Yu-Ting Liu, Sang Kang, Dan Zeng Qu Yang, Huo-Yuan Xiao, Wen-Kun Ma, Cheng-Xing Shen and Jing-Wei Pan
    Citation: Cardiovascular Diabetology 2024 23:303
  35. The binary diagnosis of Metabolic Syndrome(MetS) fails to accurately evaluate its severity, and the association between MetS severity and frailty progression remains inadequately elucidated. This study aims to...

    Authors: Peng Zeng, Minjie Li, JiXing Cao, Long Zeng, Cheng Jiang and Feng Lin
    Citation: Cardiovascular Diabetology 2024 23:302
  36. The atherogenic index of plasma (AIP) has been shown to be positively correlated with cardiovascular events. However, it remains unclear whether hypertensive patients with long-term high AIP levels are at grea...

    Authors: Huancong Zheng, Zegui Huang, Kuangyi Wu, Weiqiang Wu, Xianxuan Wang, Peng Fu, Yuxian Wang, Zekai Chen, Zefeng Cai, Zhiwei Cai, Yulong Lan, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2024 23:301
  37. Diabetes mellitus (DM) and coronary microvascular dysfunction (CMD) increase the risk of adverse cardiac events in patients with non-ST-segment elevation myocardial infarction (NSTEMI). This study aimed to eva...

    Authors: Delong Chen, Yuxuan Zhang, Abuduwufuer Yidilisi, Die Hu, Yiyue Zheng, Jiacheng Fang, Qinyan Gong, Jiniu Huang, Qichao Dong, Jun Pu, Tiesheng Niu, Jianping Xiang, Jian’an Wang and Jun Jiang
    Citation: Cardiovascular Diabetology 2024 23:300
  38. Heart failure with preserved ejection fraction (HFpEF) is associated with systemic inflammation, obesity, metabolic syndrome, and gut microbiome changes. Increased trimethylamine-N-oxide (TMAO) levels are pred...

    Authors: Salmina J. Guivala, Konrad A. Bode, Jürgen G. Okun, Ece Kartal, Edzard Schwedhelm, Luca V. Pohl, Sarah Werner, Sandra Erbs, Holger Thiele and Petra Büttner
    Citation: Cardiovascular Diabetology 2024 23:299
  39. Activation of brown adipose tissue (BAT) has gained attention due to its ability to dissipate energy and counteract cardiometabolic diseases (CMDs).

    Authors: Melina Amor, Malena Diaz, Valentina Bianco, Monika Svecla, Birgit Schwarz, Silvia Rainer, Anita Pirchheim, Laszlo Schooltink, Suravi Mukherjee, Gernot F. Grabner, Giangiacomo Beretta, Claudia Lamina, Giuseppe Danilo Norata, Hubert Hackl and Dagmar Kratky
    Citation: Cardiovascular Diabetology 2024 23:298
  40. We evaluated the prevalence of “heart stress” (HS) based on NT-proBNP cut-points proposed by the 2023 Consensus of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in asymptomati...

    Authors: Matteo Landolfo, Francesco Spannella, Federico Giulietti, Beatrice Ortensi, Lucia Stella, Maria A. Carlucci, Roberta Galeazzi, Federica Turchi, Maria P. Luconi, Roberto Zampa, Sofia Cecchi, Elena Tortato, Massimiliano Petrelli and Riccardo Sarzani
    Citation: Cardiovascular Diabetology 2024 23:297
  41. Cardiac autonomic neuropathy (CAN) in diabetes mellitus (DM) is independently associated with cardiovascular (CV) events and CV death. Diagnosis of this complication of DM is time-consuming and not routinely p...

    Authors: Katarzyna Nabrdalik, Krzysztof Irlik, Yanda Meng, Hanna Kwiendacz, Julia Piaśnik, Mirela Hendel, Paweł Ignacy, Justyna Kulpa, Kamil Kegler, Mikołaj Herba, Sylwia Boczek, Effendy Bin Hashim, Zhuangzhi Gao, Janusz Gumprecht, Yalin Zheng, Gregory Y. H. Lip…
    Citation: Cardiovascular Diabetology 2024 23:296
  42. A compromised cardiac autonomic function has been found in subjects with insulin resistance related disorders such as obesity, impaired glucose tolerance (IGT) and type 2 diabetes and confers an increased risk...

    Authors: Giuseppe Monea, Raffaele Jiritano, Luca Salerno, Mariangela Rubino, Mattia Massimino, Maria Perticone, Gaia Chiara Mannino, Angela Sciacqua, Elena Succurro, Teresa Vanessa Fiorentino and Francesco Andreozzi
    Citation: Cardiovascular Diabetology 2024 23:295
  43. Patients with concomitant type 2 diabetes mellitus (T2DM) and aortic regurgitation (AR) can present with right ventricular (RV) dysfunction. The current study aimed to evaluate the impact of AR on RV impairmen...

    Authors: Li-Ting Shen, Ke Shi, Zhi-Gang Yang, Ying-Kun Guo, Rui Shi, Yi-Ning Jiang, Wei-Feng Yan and Yuan Li
    Citation: Cardiovascular Diabetology 2024 23:294
  44. The adverse prognostic impact of diabetes on hypertrophic cardiomyopathy (HCM) is poorly understood. We sought to explore the underlying mechanisms in terms of structural and functional remodelling in HCM pati...

    Authors: Shi-Qin Yu, Ke Shi, Yuan Li, Jin Wang, Yue Gao, Rui Shi, Wei-Feng Yan, Hua-Yan Xu, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2024 23:293
  45. Atrial fibrillation (AF) is acknowledged as a disease continuum. Despite catheter ablation being recommended as a primary therapy for AF, the high recurrence rates have tempered the initial enthusiasm. Insulin...

    Authors: Yan Luo, Duan Luo, Guoshu Yang, Wenchao Huang, Yan Tang, Bao Xu, Guijun He, Yongxin Yang, Jialing He, Huaxin Sun, Lin Cai, Zhen Zhang, Hanxiong Liu and Shiqiang Xiong
    Citation: Cardiovascular Diabetology 2024 23:291
  46. Gestational diabetes mellitus (GDM) significantly impacts maternal and infant health both immediately and over the long term, yet effective early diagnostic biomarkers are currently lacking. Thus, it is essent...

    Authors: Jin Wang, Pengyu Huang, Fei Hou, Dongdong Hao, Wushan Li and Hua Jin
    Citation: Cardiovascular Diabetology 2024 23:289
  47. The impact of rosuvastatin versus atorvastatin on new-onset diabetes mellitus (NODM) among patients treated with high-intensity statin therapy for coronary artery disease (CAD) remains to be clarified. This st...

    Authors: Sung-Jin Hong, Yong-Joon Lee, Woong Chol Kang, Bum-Kee Hong, Jong-Young Lee, Jin-Bae Lee, Tae-Hyun Yang, Junghan Yoon, Seung-Jun Lee, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Yangsoo Jang and Myeong-Ki Hong
    Citation: Cardiovascular Diabetology 2024 23:287

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 8.5
    5-year Journal Impact Factor: 8.9
    Source Normalized Impact per Paper (SNIP): 1.855
    SCImago Journal Rank (SJR): 2.621

    Speed 2023
    Submission to first editorial decision (median days): 2
    Submission to acceptance (median days): 56

    Usage 2023
    Downloads: 2,523,778
    Altmetric mentions: 3,115